U.S. markets open in 39 minutes

Sana Biotechnology, Inc. (SANA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.00+0.42 (+7.53%)
At close: 04:00PM EDT
6.20 +0.20 (+3.33%)
Pre-Market: 08:30AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close5.58
Bid5.69 x 1800
Ask7.21 x 1300
Day's Range5.51 - 6.18
52 Week Range3.92 - 23.50
Avg. Volume1,292,587
Market Cap1.141B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.13
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for SANA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Sana Biotechnology, Inc.
    Daily – Vickers Top Buyers & Sellers for 03/23/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    6 months agoArgus Research
View more
  • GlobeNewswire

    Sana Biotechnology to Present at September 2022 Investor Conferences

    SEATTLE, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentations at two investor conferences in September. The presentations will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. Sana will present at the Morgan Stanley 20th Annual Global Healthcare Conference at 2:55 p.m. ET on Tuesday, September

  • Simply Wall St.

    Insiders who bought in the last 12 months lose an additional US$22k as Sana Biotechnology, Inc. (NASDAQ:SANA) drops to US$1.2b

    The recent price decline of 4.5% in Sana Biotechnology, Inc.'s ( NASDAQ:SANA ) stock may have disappointed insiders who...

  • InvestorPlace

    7 Stocks Due for a Stunning Short Squeeze

    Although the general rule of thumb is to avoid equities with heavy short interest, the new normal has brought with it new paradigms. One of these fresh approaches urges speculators to acquire short-squeeze stocks in an effort to move the equities higher, forcing the bears to cover their short positions. Of course, short covering raises the prices of the affected securities, ultimately creating a bullish bonanza. Throughout this list of short-squeeze stocks, I will refer to two concepts. The firs